Class 4 Drug Alert (Caution in use): CP Pharmaceuticals - Multiparin^® / Monoparin^® Products (Heparin Sodium) - EL (09)A08

Wockhardt UK has identified the presence of a very low level (0.6%) of over‑sulphated chondroitin sulphate (OSCS) in the active raw material used in the manufacture of 31 batches of CP Pharmaceuticals / Wockhardt UK heparin sodium injections distributed in the UK.

A Class 4 Drug Alert (Caution in use) EL (09)A08 first issued by the MHRA on 31^st March 2009 was revised on 1st April 2009.

Full details of the alert and a list of the affected batches can be found on the MHRA website: http://www.mhra.gov.uk/Publications/Safetywarnings/Drugalerts/CON041521

In anticipation of common queries, a Frequently Asked Questions (FAQ) document has been prepared.  Please see the related documents section (to the right of this information) to view this file.